Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
March 18, 2019
Form 4
Source: SEC/Edgar
March 18, 2019
Form 4
Source: SEC/Edgar
March 17, 2019
Form 4
Source: SEC/Edgar
February 19, 2019
Form 4
Source: SEC/Edgar
February 19, 2019
Form 4
Source: SEC/Edgar
January 24, 2019
Form 4
Source: SEC/Edgar
January 24, 2019
Form 4
Source: SEC/Edgar
January 24, 2019
Form 4
Source: SEC/Edgar
January 24, 2019
Form 4
Source: SEC/Edgar
January 24, 2019
Form 4
Source: SEC/Edgar
January 22, 2019
Form 4
Source: SEC/Edgar
January 16, 2019
Form 4
Source: SEC/Edgar
January 03, 2019
Form 4
Source: SEC/Edgar
January 01, 2019
Form 4
Source: SEC/Edgar
January 01, 2019
Form 4
Source: SEC/Edgar
December 13, 2018
Form 4
Source: SEC/Edgar
November 20, 2018
Form 4
Source: SEC/Edgar
November 15, 2018
Form 4
Source: SEC/Edgar
November 08, 2018
Form 4
Source: SEC/Edgar
November 06, 2018
Form 3
Source: SEC/Edgar
November 06, 2018
Form 4
Source: SEC/Edgar
October 16, 2018
Form 4
Source: SEC/Edgar
July 05, 2018
Form 4
Source: SEC/Edgar
July 02, 2018
Form 4
Source: SEC/Edgar
July 02, 2018
Form 3
Source: SEC/Edgar
June 21, 2018
Form 4
Source: SEC/Edgar
June 21, 2018
Form 4
Source: SEC/Edgar
May 23, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.